Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
- Your pictures of Scotland: 21
- Chiesi Global Rare Diseases
- Lymphatic walking: 7 things to know about the viral social media fitness trend, and what the science really says
- USDA delays start of South Carolina Healthy Food SNAP pilot
- Lawmakers remain divided over how to lower healthcare costs
- Long-Awaited PlayStation 5 Action Game Gets Release Date Window
- Additional deaths linked to Legionnaires’ outbreak on Upper East Side
- Scientists Identify a Single Protein That May Control Cravings For Fatty Foods
Browsing: Wins
Recovered waste heat expected to provide customer with an additional $410-472 thousand in annual natural gas savings
Israeli gymnast Artem Dolgopyat added another major achievement to his remarkable career on Friday, capturing the European Championship title in the floor exercise in Zagreb
This kind of move into rare disease therapies is part of a broader push across healthcare to develop more precise, technology driven treatments. You can explore other companies linked to this theme through 42 healthcare AI stocks
Regeneron has won FDA approval for garetosmab in fibrodysplasia ossificans progressiva, giving the biotech a commercial product built on its scientific breakthrough in the ultrarare disease. It also sets up a showdown with Ipsen, which owns the only other FOP drug on the market
Patrick Moore has finally found his jackpot and is headed to the Olympia final after winning the IFBB Texas Pro in Irving on August 14. Moore’s Open division victory was one of ten hotly contested categories, as the road to the industry’s biggest show draws near
Defense Health Agency team wins program management award for securing FDA clearance of canine plasma
DVIDS – News – Defense Health Agency team wins program management award for securing FDA clearance of canine plasma
Del Mar Benoit PhotoMike Smith embraces Clifford Sise after winning aboard Sise trainee Danzing Flyer on July 26.
Eli Lilly’s Foundayo (orforglipron) has secured UK regulatory approval for weight management and type 2 diabetes, making the UK the first European country to authorise the once-daily GLP-1 tablet
When Phynova’s name was announced as the winner of the 2026 NutraIngredients-USA Award for Nutrition Research Project of the Year, Director of Marketing Americas Jewell Blackwell’s emotional reaction quickly became one of the night’s most memorable moments
|| Interior view of Hanmi Pharmaceutical’s Pyeongtaek manufacturing center. Photo courtesy of Hanmi Pharmaceutical

